HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Chronic primary epigastric pain syndrome — Clinical Guidelines

Overview

Chronic primary epigastric pain syndrome refers to persistent abdominal pain localized to the epigastric region without identifiable organic causes, often challenging to diagnose and manage effectively. 1 3

Diagnosis

Clinical evaluation focusing on exclusion of organic causes through imaging and laboratory tests.

Symptom scoring tools like NIH-CPSI may be adapted for symptom assessment, though specific validation for epigastric pain is limited. 1

No specific diagnostic tests universally recommended; imaging (TRUS, MR venography) may help rule out other conditions. 1

Management

First-line treatments:

- Acupuncture shows preliminary promise with significant reduction in pain scores; bilateral BL-33 points targeted weekly for 5 weeks. (Evidence: Moderate) 1

Adjunctive treatments:

- Vitamin supplementation may offer mild benefits, particularly in addressing subclinical deficiencies in thiamin, riboflavin, and folic acid, though robust evidence is lacking. (Evidence: Weak) 3 - Sympatholytic agents like phentolamine and clonidine have conflicting evidence and require cautious use without strong recommendation. 2

Special Populations

Pregnancy: No specific data provided in the abstracts.

Pediatrics: No specific data provided in the abstracts.

Elderly: No specific data provided in the abstracts.

Comorbidities: Management considerations may overlap with conditions like chronic pelvic pain, but specific guidance for comorbidities is not detailed in the provided abstracts. 1 2 3

Key Recommendations

Consider acupuncture as a first-line adjunctive therapy targeting BL-33 points for 5 weekly sessions in patients with chronic primary epigastric pain syndrome, given preliminary evidence of symptom improvement. (Evidence: Moderate) 1

Evaluate and address subclinical vitamin deficiencies, particularly thiamin, riboflavin, and folic acid, through supplementation, though efficacy in pain reduction is modest. (Evidence: Weak) 3

Approach sympatholytic treatments with caution due to conflicting evidence and lack of robust clinical trials supporting their use in chronic primary epigastric pain syndrome. (Evidence: Weak) 2

References

1 Honjo H, Kamoi K, Naya Y, Ukimura O, Kojima M, Kitakoji H et al.. Effects of acupuncture for chronic pelvic pain syndrome with intrapelvic venous congestion: preliminary results. International journal of urology : official journal of the Japanese Urological Association 2004. link 2 Dotson RM. Causalgia--reflex sympathetic dystrophy--sympathetically maintained pain: myth and reality. Muscle & nerve 1993. link 3 Mäder R, Deutsch H, Siebert GK, Gerbershagen HU, Grühn E, Behl M et al.. Vitamin status of inpatients with chronic cephalgia and dysfunction pain syndrome and effects of a vitamin supplementation. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 1988. link

Chronic primary epigastric pain syndrome